is semaglutide bad for kidneys in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial Ozempic for Chronic Kidney Disease:

In-person or at-home telehealth

Hair loss during GLP-1 therapy concerns many patients, but the connection is not with the medication itselfit stems from the physiological stress of rapid weight loss

For perspective, RLMI's 15-Day Whole-Food Plant-Based Jumpstart produces an average loss of 5.8 pounds in 15 days , and 7.3 pounds for participants with a BMI over 30

When administered by qualified professionals, glutathione injections are generally safe, but potential side effects and individual suitability should always be discussed

Persistent fatigue combined with muscle weakness, difficulty concentrating, or mood changes warrants evaluation for thyroid dysfunction, anemia, or depression